Bristol-Myers falls on report there are no talks going on with AstraZeneca
· seekingalpha.com
BMY slips as Reuters says no active AstraZeneca deal talks, despite earlier reports.
Bristol-Myers Squibb (BMY) dropped 1.4% in premarket trading after a report that there are no discussions happening with AstraZeneca (AZN) about a potential dea...